- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03766009
유방암 수술 의사 결정에 대한 환자의 참여 증가
공동 의사결정 개입을 통한 유방암 수술 의사결정에 대한 사회경제적 혜택을 받지 못하는 환자의 참여 증가
This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely to be experienced by socioeconomically disadvantaged patients.
연구 개요
상세 설명
The primary and secondary objectives of the study:
PRIMARY OBJECTIVES:
I. Test the effectiveness of a breast cancer surgery decision aid in increasing patient engagement in decision making (measured by knowledge and power) in clinics serving a high proportion of socioeconomically disadvantaged patients.
II. Test the extent to which the effect of a decision aid on patient engagement is mediated through the mitigation of barriers and determine if persistent barriers are disproportionately experienced by socioeconomically disadvantaged patients.
SECONDARY OBJECTIVES:
I. Characterize how persistent barriers influence patient engagement in decision making in order to identify targets for adjunct interventions that could be implemented in clinics serving a high proportion of socioeconomically disadvantaged patients.
Trial Design:
OUTLINE: This is a multi-site cluster randomized trial using a stepped wedge design. Ten clinics will be recruited for participation. All clinics will begin in the usual care arm. Clinics will be randomized to the timing with which they cross-over to the decision aid intervention, with new clinics crossing over every 10 weeks.
ARM I: usual care
ARM II: decision aid intervention
The only difference between patients enrolled before institutional crossover and patients enrolled after institutional crossover is those who are enrolled after institutional crossover will have been offered the decision aid as accepted practice in the clinic.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Tamuning, 괌, 96913
- FHP Health Center-Guam
-
-
-
-
California
-
Dublin, California, 미국, 94568
- Epic Care-Dublin
-
Emeryville, California, 미국, 94608
- Bay Area Breast Surgeons Inc
-
Emeryville, California, 미국, 94608
- Epic Care Partners in Cancer Care
-
Martinez, California, 미국, 94553-3156
- Contra Costa Regional Medical Center
-
Oakland, California, 미국, 94609
- Alta Bates Summit Medical Center - Summit Campus
-
Oakland, California, 미국, 94609
- Bay Area Tumor Institute
-
Walnut Creek, California, 미국, 94597
- Epic Care Cyberknife Center
-
-
Georgia
-
Augusta, Georgia, 미국, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, 미국, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, 미국, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, 미국, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, 미국, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, 미국, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, 미국, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, 미국, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, 미국, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, 미국, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, 미국, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, 미국, 96813
- Island Urology
-
Lihue, Hawaii, 미국, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, 미국, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, 미국, 96701
- Queen's Cancer Center - Pearlridge
-
‘Aiea, Hawaii, 미국, 96701
- The Cancer Center of Hawaii-Pali Momi
-
‘Aiea, Hawaii, 미국, 96701
- Hawaii Cancer Care - Savio
-
-
Idaho
-
Boise, Idaho, 미국, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Caldwell, Idaho, 미국, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, 미국, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, 미국, 83617
- Walter Knox Memorial Hospital
-
Meridian, Idaho, 미국, 83642
- Idaho Urologic Institute-Meridian
-
Nampa, Idaho, 미국, 83686
- Saint Alphonsus Medical Center-Nampa
-
Post Falls, Idaho, 미국, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, 미국, 83864
- Kootenai Cancer Clinic
-
-
Illinois
-
Chicago, Illinois, 미국, 60612
- John H Stroger Jr Hospital of Cook County
-
Danville, Illinois, 미국, 61832
- Carle on Vermilion
-
Effingham, Illinois, 미국, 62401
- Carle Physician Group-Effingham
-
Mattoon, Illinois, 미국, 61938
- Carle Physician Group-Mattoon/Charleston
-
Urbana, Illinois, 미국, 61801
- Carle Cancer Center
-
Urbana, Illinois, 미국, 61801
- The Carle Foundation Hospital
-
-
Louisiana
-
New Orleans, Louisiana, 미국, 70121
- Ochsner Medical Center Jefferson
-
-
Montana
-
Anaconda, Montana, 미국, 59711
- Community Hospital of Anaconda
-
Billings, Montana, 미국, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, 미국, 59715
- Bozeman Deaconess Hospital
-
Great Falls, Montana, 미국, 59405
- Great Falls Clinic
-
Great Falls, Montana, 미국, 59405
- Benefis Healthcare- Sletten Cancer Institute
-
Helena, Montana, 미국, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, 미국, 59901
- Kalispell Regional Medical Center
-
Missoula, Montana, 미국, 59804
- Community Medical Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87102
- University of New Mexico Cancer Center
-
-
Oregon
-
Baker City, Oregon, 미국, 97814
- Saint Alphonsus Medical Center-Baker City
-
Ontario, Oregon, 미국, 97914
- Saint Alphonsus Medical Center-Ontario
-
-
South Carolina
-
Charleston, South Carolina, 미국, 29425
- Medical University of South Carolina
-
-
Virginia
-
Richmond, Virginia, 미국, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, 미국, 23298
- Virginia Commonwealth University/Massey Cancer Center
-
-
Wisconsin
-
Marshfield, Wisconsin, 미국, 54449
- Marshfield Medical Center-Marshfield
-
-
Wyoming
-
Cody, Wyoming, 미국, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, 미국, 82801
- Welch Cancer Center
-
-
-
-
-
San Juan, 푸에르토 리코, 00902
- Pan American Center for Oncology Trials LLC
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Newly diagnosed with stage 0-III breast cancer
- Eligible patients must be planning breast surgery as a component of their definitive treatment
- Patients with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss) are not eligible for this study
- Patients with hearing impairment requiring the use of an interpreter are not eligible for this study
- Patients must be able to speak English with the fluency required to have a direct discussion around treatment decision-making (i.e. without interpreter)
- CLINIC STAKEHOLDER (SURGEONS AND CLINIC STAFF): Breast surgeon(s) and nursing staff, medical assistant, or mid-level provider at each participating clinic who participates in the care of patients newly diagnosed with breast cancer
- INSTITUTIONAL: 10 clinics that annually provide surgical care for 120-300 patients newly diagnosed with breast cancer will be selected to participate in this study
- INSTITUTIONAL: Surgeons at eligible clinics must consent to the study as a requirement for site participation
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Arm I (surgical consultation)
Prior to institutional crossover, participants receive care as per usual care. |
Usual Care |
|
실험적: Arm II (web-based breast cancer surgery decision aid)
Following a 10 week implementation period, at the time of institutional crossover, participants will receive a web-based decision aid prior to the surgical consultation.. |
Usual Care Web-based decision aid received prior to the surgical consultation |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Patient Power: Self-efficacy in Patient Physician Interactions
기간: 3 weeks
|
Power is defined as patients' self-perceived capacity to influence the decision-making encounter. This construct is measured using the Patient's Self-Efficacy in Patient-Physician Interactions (PEPPI)-5 point scale; the primary outcome measure is a total score ranging from 5-25, where higher scores indicate increased self-efficacy. The patient completes the PEPPI-5 questionnaire within 3 weeks post-surgical consultation. |
3 weeks
|
|
Patient Power: Active Patient Participation
기간: 1 day
|
Power is also separately measured by the validated Active Patient Participation Behaviors System to assess active patient participation during the surgeon consultation and is measured off the audio-recording of the consultation; a summary measure of patient's active involvement in the interaction is coded by the study team and represents a total count of patients' communicative behaviors (i.e., count of patient asking questions, count of patient assertive responses and count of patient expressions of concern) ranging from 0-114, where higher scores indicate increased active patient participation. The consultation for a patient will typically be study day 1 (day of registration). |
1 day
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Patient Knowledge
기간: Up to 3 weeks
|
Patient knowledge is measured from 5 knowledge questions in the Decision Quality Instrument-Breast Surgery survey, with a percent correct recorded as the secondary outcome measure, ranging from 0-100%. The patient completes the Decision Quality Instrument-Breast Surgery survey within 3 weeks post-surgical consultation. |
Up to 3 weeks
|
|
Percentage of Concordant Between Surgery Received and Patient Treatment Preference
기간: Up to 3 weeks
|
This binary outcome indicates whether the surgery received (mastectomy or lumpectomy) was concordant with the patient's treatment preference. Patient's goals/concerns (keep the breast, remove the breast for peace of mind, avoid radiation), rated from 0 (not at all important) to 10 (extremely important), and treatment preference (lumpectomy only, lumpectomy and radiation, mastectomy, other surgery, or not sure) are measured with the Decision Quality Instrument (DQI)-Breast Surgery survey, completed within 3 weeks post-consultation. Concordance is derived using the method of Sepucha et al. (2012): (1) estimate a predicted probability (pp) of surgery preference from a multivariable logistic regression model with patient's goals/concerns and stage as independent variables; (2) classify patients as concordant if pp >= 0.5 and mastectomy was received, or pp < 0.5 and lumpectomy was received; and (3) calculate the percentage of concordant. |
Up to 3 weeks
|
공동 작업자 및 조사자
수사관
- 연구 의자: Heather B. Neuman,, MD, MS, University of Wisconsin, Madison
간행물 및 유용한 링크
일반 간행물
- Schumacher JR, Zahrieh D, Chow S, Taylor J, Wills R, Hanlon BM, Rathouz PJ, Tucholka JL, Neuman HB. Increasing socioeconomically disadvantaged patients' engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trial. BMJ Open. 2022 Nov 17;12(11):e063895. doi: 10.1136/bmjopen-2022-063895.
- Schumacher JR, Hanlon BM, Zahrieh D, Rathouz PJ, Tucholka JL, McKinney G, Tan AD, Breuer CR, Bailey L, Higham AM, Wecsler JS, Arnold AH, Froix AJ, Dull S, Abbott AM, Fine SG, McGuire KP, Seydel AS, McNamara P, Chow S, Neuman HB. Impact of a Web-Based Decision Aid on Socioeconomically Disadvantaged Patients' Engagement in Breast Surgery Decision-Making: Stepped-Wedge Clinical Trial (Alliance-A231701CD). Ann Surg Oncol. 2025 Aug;32(8):5540-5550. doi: 10.1245/s10434-025-17452-0. Epub 2025 May 17.
- Saucke MC, Jacobson N, McKinney G, Neuman HB. Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD. Ann Surg Oncol. 2024 Dec;31(13):8873-8881. doi: 10.1245/s10434-024-16156-1. Epub 2024 Sep 25.
- Zahrieh D, Croghan IT, Inselman JW, Mandrekar SJ. Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case Studies. Mayo Clin Proc. 2023 Nov;98(11):1712-1726. doi: 10.1016/j.mayocp.2023.02.019.
- Saucke MC, Jacobson N, Chow S, McKinney G, Neuman HB. Providing information to prepare breast cancer patients for their surgical consultation: barriers and recommendations (an analysis from Alliance A231701CD). Support Care Cancer. 2026 May 14;34(6):537. doi: 10.1007/s00520-026-10726-7.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- A231701CD
- NCI-2018-00643 (레지스트리 식별자: NCI Clinical Trial Reporting Program)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
IPD 공유 기간
Beginning 6 to 12 months following article publication.
IPD 공유 액세스 기준
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .